Robert Hayashi, MD

Bone Marrow Transplant Specialist, Pediatric Hematologist/Oncologist

Robert Hayashi

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

My Locations

Siteman Kids at St. Louis Children’s Hospital

Siteman Kids at St. Louis Children’s Hospital

On WashU Medicine Campus
1 Children's Place, St. Louis, MO 63110

Expertise & Training

Clinical Expertise

  • Pediatric Cancer, Bone Marrow Transplantation

     

Primary Academic Title

Professor of Pediatrics, Division of Hematology/Oncology, WashU Medicine

Board Certification

  • 1989: American Board of Pediatrics, General Pediatrics
  • 1992: American Board of Pediatrics, Pediatric Hematology/Oncology
  • 1998: American Board of Pediatrics, General Pediatrics
  • 1998: American Board of Pediatrics, Pediatric Hematology/Oncology

Training

  • 1986 - 1989: Intern and Resident, Pediatrics, WashU Medicine, St. Louis, MO
  • 1989 - 1992: Fellow, Pediatric Hematology/Oncology, Johns Hopkins University, Baltimore, MD

Education

  • 1986: MD, Washington University School of Medicine, St. Louis, MO

Research & Selected Publications

Research Interest

Basic laboratory interests include mechanisms of T cell tolerance and the role of cytokines in the immune response. Clinical interests include bone marrow transplantation and pediatric oncology.

Research Publications

Ototoxicity in Pediatric Hematopoietic Stem Cell Transplantation With High-Dose Carboplatin: Identifying Modifiable Risk Factors Through the Inclusion of Younger Patients
Authors:

Spence A, Camet M, Hayashi SS, one or more additional authors omitted Hayashi RJ

Journal & Year:

Pediatr Blood Cancer | 2025

Risk factors for neurocognitive impairment, emotional distress, and poor quality of life in survivors of pediatric rhabdomyosarcoma: A report from the Childhood Cancer Survivor Stu…
Authors:

van der Plas E, Darji H, Srivastava DK, one or more additional authors omitted Hayashi RJ

Journal & Year:

Cancer | 2024

MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231
Authors:

Hayashi RJ, Hermiston ML, Wood BL, one or more additional authors omitted Allen CE

Journal & Year:

Blood | 2024

Late effects in survivors of post-transplant lymphoproliferative disease
Authors:

McGlynn MC, Brady K, Healey JM, one or more additional authors omitted Hayashi RJ

Journal & Year:

Pediatr Blood Cancer | 2024

Assessing quality of life in childhood cancer survivors at risk for hearing loss: a comparison of HEAR-QL and PROMIS measures
Authors:

Spence A, L'Hotta AJ, Hayashi SS, one or more additional authors omitted Hayashi RJ

Journal & Year:

Front Oncol | 2024

PET scans for non-Hodgkin lymphoma: Answering the critical questions to assess utility
Authors:

Hayashi RJ

Journal & Year:

Pediatr Blood Cancer | 2023

Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Authors:

Bhatia S, Pappo AS, Acquazzino M, one or more additional authors omitted Hayashi R, one or more additional authors omitted Hang L

Journal & Year:

J Natl Compr Canc Netw | 2023

Characterization of vision in pediatric retinoblastoma survivors beyond visual acuity
Authors:

Reynolds M, Wise J, Wu T, one or more additional authors omitted Hayashi R

Journal & Year:

J AAPOS | 2023